FDA product code LAT: Radioimmunoassay, Cannabinoid(S)

LAT is the FDA product code for radioimmunoassay, cannabinoid(s). It is a Class II device, regulated under 21 CFR 862.3870 and reviewed by the Clinical Toxicology panel. FDA has cleared 16 510(k) submissions under LAT, from 7 different applicants. The average 510(k) review took 122 days (median 57).

Classification

FieldValue
Device nameRadioimmunoassay, Cannabinoid(S)
Device classClass II
Regulation21 CFR 862.3870
Review panelTX — Clinical Toxicology
Medical specialtyClinical Toxicology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every LAT clearance

Top LAT applicants

ApplicantClearancesLatest
Immunalysis Corporation71991-09-18
Roche Diagnostic Systems, Inc.41996-06-13
Psychemedics Corp.12002-05-03
Sudormed, Inc.11996-06-10
Diagnostic Products Corp.11991-12-18

2 more applicants have LAT clearances. See the full list in Caduvo.

Most recent LAT clearances

510(k)ApplicantDeviceDecision dateReview days
K011426Psychemedics Corp.PSYCHEMEDICS RIA CANNABINOID ASSAY2002-05-03360
K961620Roche Diagnostic Systems, Inc.ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/1001996-06-1348
K936135Sudormed, Inc.SUDORMED SWEAT PATCH SPECIMEN CONTAINER FOR COLLECTION OF MARIJUANA IN PERSPIRATION1996-06-10895
K914507Diagnostic Products Corp.DOUBLE ANTIBODY CANNABIONOIDS/QUAIL DETER IN URINE1991-12-1870
K913414Roche Diagnostic Systems, Inc.ABUSCREEN(R) ONLINE(TM) FOR THC(50/100)(100TEST KT1991-09-2562

Recalls for LAT devices

openFDA lists no recalls for product code LAT.

Frequently asked questions

What is FDA product code LAT?

LAT is the FDA product code for radioimmunoassay, cannabinoid(s). It is a Class II device, regulated under 21 CFR 862.3870 and reviewed by the Clinical Toxicology panel.

What device class is LAT?

Class II, regulation 21 CFR 862.3870. Typical premarket route: 510(k).

How long does a 510(k) take for product code LAT?

Across 16 cleared submissions the average was 122 days from receipt to decision (median 57).

Which companies have the most LAT clearances?

Immunalysis Corporation (7); Roche Diagnostic Systems, Inc. (4); Psychemedics Corp. (1); Sudormed, Inc. (1); Diagnostic Products Corp. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times